Europe Clinical Trials Supplies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product & Service (Manufacturing, Packaging & Labelling, and Logistics & Distribution), Stage (Phase I, Phase II, Phase III, and Bioequivalence Studies), Drug Type (Small-Molecule Drugs and Biologic Drugs), and Application (Oncology, Cardiovascular Diseases, Neurological Disorders, Respiratory Disorders, and Others)
Market Introduction
The clinical trial is an investigation study that defines whether a medical approach, therapy, or device is effective, safe, and useful for human applications. These studies help to find which therapeutic approaches experiment is best for certain diseases. Clinical trial supplies management is necessary for evading overproduction, oversupply, and inventory expiration. With the increasing costs of drug discovery, clinical trial supplies are obtaining more importance.
Get more information on this report :
Market Overview and Dynamics
The Europe clinical trial supplies market is expected to reach US$ 938.54 Mn by 2027 from US$ 550.28 Mn in 2019; it is estimated to grow at a CAGR of 7.0% from 2020 to 2027. The growth of the market is attributed to some key driving factors such as increasing R&D expenditures in the pharmaceutical & biopharmaceutical companies and increase in the number of clinical trials. However, challenges for clinical trials due to negative impact of COVID-19 pandemic is expected to restraint the growth of the market during the forecast years.
Clinical trial supplies management is necessary for evading overproduction, oversupply, and inventory expiration. With the increasing costs of drug discovery, clinical trial supplies are obtaining more importance. A rise in outsourcing activities by pharmaceutical companies has been witnessed during recent years. The major factors driving the outsourcing activities by companies include cost cutting, need for innovations, increased speed and agility, and access to specialized knowledge and technologies. Hence, with an increase in the R&D expenditure, the need for clinical trial outsourcing is increasing. Furthermore, the collaborative research between the research & development team of the sponsoring company as well as contract developer is a new trend being employed in the market. In addition, the emerging trend of outsourcing has led to rise in development of drug candidates and clinical trials by pharmaceutical and biotechnology companies, which is also expected to account for the growth of the market over the coming years. Also, factors such as increasing R&D expenditures in the pharmaceutical & biopharmaceutical companies and rising number of clinical trials will bolster the market growth.
Since the surge of COVID-19 cases, the pharmaceutical industry is facing a decrease in production capabilities, resulting in drug shortages. Moreover, diversion of resources from drug development to coronavirus treatment is likely to hamper overall productivity of the drug development for a short period of span. Various pharmaceutical companies made decisions to postpone the ongoing clinical trials due to disrupted supply chains and threat of the virus. However, the procedures and practices have now re-initiated due to economic losses in the commercial sector in North America. Thus, the COVID-19 pandemic had a positive as well as negative impact on the Europe clinical trial supplies market.
Key Market Segments
Based on product & service, the Europe clinical trial supplies market is segmented into manufacturing, packaging & labelling, and logistics & distribution. The logistics & distribution segment held the largest share of the market in 2019; the same segment is anticipated to register the highest CAGR in the market during the forecast period.
In terms of stage, the Europe clinical trial supplies market is segmented into phase I, phase II, phase III, and bioequivalence studies. The phase III segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.
Based on drug type, the Europe clinical trial supplies market is segmented into small-molecule drugs and biologic drugs. The small-molecule drugs segment held the largest share of the market in 2019, whereas the biologic drugs segment is estimated to register the highest CAGR in the market during the forecast period.
Based on application, the Europe clinical trial supplies market has been segmented into oncology, cardiovascular diseases, neurological disorders, respiratory disorders, and others. The oncology segment held the largest share of the market in 2019 and is estimated to register the highest CAGR during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the Europe clinical trial supplies market are the European Federation of Pharmaceuticals Industries Associations (EFPIA), European Medical Association (EMA), UK Clinical Research Collaboration (UKCRC) and European CRO Federation (EUCROF).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of Europe clinical trial supplies market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Europe clinical trial supplies market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe clinical trial supplies market.
EUROPE CLINICAL TRIAL SUPPLIES MARKET SEGMENTATION
By Product & Service
- Manufacturing
- Packaging & Labelling
- Logistics & Distribution
By Stage
- Phase I
- Phase II
- Phase III
- Bioequivalence Studies
By Drug Type
- Small-molecule Drugs
- Biologic Drugs
By Application
- Oncology
- Cardiovascular Diseases
- Neurological Disorders
- Respiratory Disorders
- Others
By Country
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- THERMO FISHER SCIENTIFIC INC.
- UDG Healthcare plc
- Catalent Inc.
- pci Pharma Services
- Almac Group
- PAREXEL INTERNATIONAL CORPORATION
- Biocair
- Owens & Minor Inc
- Rubicon Research Pvt. Ltd
- CLINICAL SUPPLIES MANAGEMENT HOLDINGS, INC.
- KLIFO
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Clinical Trial Supplies Market – By Product & Service
1.3.2 Europe Clinical Trial Supplies Market – By Stage
1.3.3 Europe Clinical Trial Supplies Market – By Drug Type
1.3.4 Europe Clinical Trial Supplies Market – By Application
1.3.5 Europe Clinical Trial Supplies Market – By Country
2. Clinical Trial Supplies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Clinical Trial Supplies Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe – PEST Analysis
4.3 Expert Opinion
5. Clinical Trial Supplies Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Pharmaceutical and Biopharmaceutical R&D Expenditures
5.1.2 Higher Cost of Drug Development Process in Developed Countries
5.2 Market Restraints
5.2.1 Rising Cost of Drug Development and Clinical Trials
5.2.2 Challenges for Clinical Trials Due to Negative Impact of Corona Virus
5.3 Future Trends
5.3.1 Growing Biosimilars and Biologics Market
5.4 Impact analysis
6. Clinical Trial Supplies Market – Europe Analysis
6.1 Europe Clinical Trial Supplies Market Revenue Forecast and Analysis
7. Clinical Trial Supplies Market Analysis – By Product and Service
7.1 Overview
7.2 Clinical Trial Supplies Market Revenue Share, by Product and Service (2019 and 2027)
7.3 Logistics & Distribution
7.3.1 Overview
7.3.2 Logistics & Distribution: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Manufacturing
7.4.1 Overview
7.4.2 Manufacturing: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Packaging & Labelling
7.5.1 Overview
7.5.2 Packaging & Labelling: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
8. Clinical Trial Supplies Market – By Stage
8.1 Overview
8.2 Clinical Trial Supplies Market, by Stage, 2019 and 2027 (%)
8.3 Phase III
8.3.1 Overview
8.3.2 Phase III: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Phase II
8.4.1 Overview
8.4.2 Phase II: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Bioequivalence Studies
8.5.1 Overview
8.5.2 Bioequivalence Studies: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Phase I
8.6.1 Overview
8.6.2 Phase I: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
9. Clinical Trial Supplies Market – By Drug Type
9.1 Overview
9.2 Clinical Trial Supplies Market, by Drug Type 2019 and 2027 (%)
9.3 Small-molecule Drugs
9.3.1 Overview
9.3.2 Small-molecule Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Biologic Drugs
9.4.1 Overview
9.4.2 Biologic Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
10. Clinical Trial Supplies Market – By Application
10.1 Overview
10.2 Clinical Trial Supplies Market, by Application 2019 and 2027 (%)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
10.4 Cardiovascular Diseases
10.4.1 Overview
10.4.2 Cardiovascular Diseases: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
10.5 Neurological Disorders
10.5.1 Overview
10.5.2 Neurological Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
10.6 Respiratory Disorders
10.6.1 Overview
10.6.2 Respiratory Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
11. Clinical Trial Supplies Market – Europe Analysis
11.1 Europe: Clinical Trial Supplies Market
11.1.1 Overview
11.1.2 Europe: Clinical Trial Supplies Market, by Country, 2018 & 2027 (%)
11.1.3 Germany: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.3.1 Germany: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.3.2 Germany: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.1.3.3 Germany: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.1.3.4 Germany: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.1.3.5 Germany: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.1.4 UK: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.4.1 UK: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.4.2 UK: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.1.4.3 UK: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.1.4.4 UK: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.1.4.5 UK: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.1.5 France: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.5.1 France: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.5.2 France: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.1.5.3 France: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.1.5.4 France: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.1.5.5 France: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.1.6 Spain: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.6.1 Spain: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.6.2 Spain: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.1.6.3 Spain: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.1.6.4 Spain: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.1.6.5 Spain: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
11.1.7 Italy: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.7.1 Italy: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
11.1.7.2 Italy: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)
11.1.7.3 Italy: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)
11.1.7.4 Italy: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)
11.1.7.5 Italy: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)
12. Impact of COVID-19 Pandemic on Europe Clinical Trial Supplies Market
12.1 Europe: Impact assessment of COVID-19 Pandemic
13. Clinical Trials Supplies Market – Industry Landscape
13.1 Overview
13.2 Organic Developments
13.2.1 Overview
13.3 Inorganic Developments
13.3.1 Overview
14. Clinical Trial Supplies Market – Key Company Profiles
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 UDG Healthcare plc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Catalent Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 pci Pharma Services
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Almac Group
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 PAREXEL INTERNATIONAL CORPORATION
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Biocair
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Owens & Minor Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 KLIFO
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 CLINICAL SUPPLIES MANAGEMENT HOLDINGS, INC.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 2. Germany Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 3. Germany Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 4. Germany Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 5. UK Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 6. UK Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 7. UK Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 8. UK Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. France Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 10. France Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 11. France Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 12. France Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 13. Spain Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 14. Spain Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 15. Spain Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 16. Spain Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 17. Italy Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)
Table 18. Italy Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)
Table 19. Italy Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 20. Italy Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 21. Organic Developments Done by Companies
Table 22. Inorganic Developments Done by Companies
Table 23. Glossary of Terms, Clinical Trial Supplies Market
LIST OF FIGURES
Figure 1. Clinical Trial Supplies Market Segmentation
Figure 2. Clinical Trial Supplies Segmentation, By Country
Figure 3. Europe Clinical Trial Supplies Market Overview
Figure 4. Logistics & Distribution Segment Held Largest Share of Product & Service Segment in Clinical Trial Supplies Market
Figure 5. Phase III Segment Held Largest Share of Stage Segment in Clinical Trial Supplies Market
Figure 6. Small-molecule Drugs Segment Held Largest Share of Drug type Segment in Clinical Trial Supplies Market
Figure 7. Oncology Segment Held Largest Share of Application Segment in Clinical Trial Supplies Market
Figure 8. Europe Clinical Trial Supplies Market- Leading Country Markets (US$ Million)
Figure 9. Europe PEST Analysis
Figure 10. Clinical Trial Supplies Market Impact Analysis of Drivers and Restraints
Figure 11. Europe Clinical Trial Supplies Market – Revenue Forecast and Analysis – 2019- 2027
Figure 12. Clinical Trial Supplies Market Revenue Share, by Product and Service (2019 and 2027)
Figure 13. Logistics & Distribution: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Manufacturing: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Packaging & Labelling: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Clinical Trial Supplies Market, by Stage 2019 and 2027 (%)
Figure 17. Phase III: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Phase II: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Bioequivalence Studies: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Phase I: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Clinical Trial Supplies Market, by Drug Type, 2019 and 2027 (%)
Figure 22. Small-molecule Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Biologics Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Clinical Trial Supplies Market, by Application, 2019 and 2027 (%)
Figure 25. Oncology: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Cardiovascular Diseases: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Neurological Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Respiratory Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Others: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. Europe: Clinical Trial Supplies Market, by Key Country – Revenue (2019) (USD Million)
Figure 31. Europe: Clinical Trial Supplies Market, by Country, 2018 & 2027 (%)
Figure 32. Germany: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. UK: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. France: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Spain: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Italy: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in European Country Markets
- THERMO FISHER SCIENTIFIC INC.
- UDG Healthcare plc
- Catalent Inc.
- pci Pharma Services
- Almac Group
- PAREXEL INTERNATIONAL CORPORATION
- Biocair
- Owens & Minor Inc
- Rubicon Research Pvt. Ltd
- CLINICAL SUPPLIES MANAGEMENT HOLDINGS, INC.
- KLIFO
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe clinical trial supplies market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe clinical trial supplies market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.